Our previous studies showed that PDK4 inhibition by DCA protects against obesity-associated insulin resistance via regulation of adipose tissue inflammation [22], atherosclerosis [23], and diabetes [24]. Here, PDK4 is linked to obesity due to melanocortin 4 receptor deficiency.